• Logo

Programme

THURSDAY, 20TH JULY 2017

WORKSHOP: Acute pulmonary embolism to chronic thromboembolic pulmonary hypertension

(CTEPH): State of the art management

Organised in collaboration with the Pulmonary Vascular Research Institute

0830-0900 Pulmonary embolism: A background
0900-0930 Case Discussion 1: Risk stratification
0930-1000 The role of imaging in pulmonary embolism
1000-1030 Management of confirmed pulmonary embolism
1030-1100 Coffee break
1100-1130 Case Discussion 2: To thrombolyse or not to thrombolyse? 
1130-1200 Case Discussion 3: The argument for and against lifelong anticoagulation
1200-1230 Management of bleeding in anti-coagulated patients
1230-1330 Lunch break
1330-1400 Case Discussion 4: CTEPH – an easily missed-diagnosis
1400-1430 Investigating suspected CTEPH
1430-1500 Medical intervention for CTEPH – do the drugs work?
1500-1515 Coffee break
1515-1545 Balloon pulmonary angioplasty
1545-1615 The surgical approach to CTEPH
1615 Close
1630-1730 Meeting of Pulmonary Vascular Research Institute Regional Taskforce
1845-1935 Sponsored Symposium 1A
(SS1A)
Sponsored Symposium 1B
(SS1B)

FRIDAY, 21ST JULY 2017

0700-0800 Registration
0800-0810 Welcome Address by:
• MTS Annual Congress 2017 Organising Chairman
• MTS President
0810-0850 PLENARY 1 (P1)
Plenary Title: The Future of Pulmonary Hypertension
0850-1005 SYMPOSIUM 1 (S1)
S1A – Occupational and Environmental Lung Disease

• The impact of environmental factors on lung defences
• Climate change and lung disease
• Occupational ILD

S1B – Ethics & medicolegal matters
• Palliative care – when, where and how?
• Implementing a culture of safety
• Combating pseudoscience

S1C – Difficult asthma in children
• Difficult asthma in children, who are they?
• Severe allergy asthma
• Best way to recognize and manage Brittle asthma in children
1005-1035 Coffee break
1035-1150  SYMPOSIUM 2 (S2)
S2A – Tuberculosis I

• Review of National Tuberculosis Control Programme
• Finding the missing cases
• Tuberculosis in children

S2B – Pulmonary manifestations of systemic disease
• Sarcoidosis
• Pleural disease
• Lung-dominant connective tissue disease

S2C – Current childhood asthma phenotypes
• Asthma phenotypes based on clinical and symptoms
• Childhood asthma and genetic, what is the clinical application?
• Phenotype focus management, is it practical?
1150-1240 SPONSORED SYMPOSIUM 2 (SS2)
Company: AstraZeneca
1240-1430 Lunch and Friday prayers
1430-1600 SYMPOSIUM 3 (S3)
S3A – Pleural Disease

• Malignant pleural effusion randomised trials: AMPLE TIME or ASAP?
• Empyema
• VATS – when to call a surgeon

S3B – Sleep-disordered breathing
• Obstructive sleep apnoea and the metabolic syndrome
• When to call a neurologist?
• Obesity hypoventilation syndrome

S3C – Primary immumedeficiency (PID) and respiratory complications
• Overview of primary immune deficiency in children
• Respiratory complications in primary immune deficiency
• Optimal management for children with PID
1600-1650 SPONSORED SYMPOSIUM 3 (SS3A)
Company: GlaxoSmithKline Pharmaceutical

SPONSORED SYMPOSIUM 3 (SS3B)

Company: Sanofi Pasteur 
1650-1845 Coffee break and MTS Annual General Meeting
1845-1935 SPONSORED SYMPOSIUM 4 (SS4)
Company: Roche 
1935-2200 Dinner

SATURDAY, 22ND JULY 2017

0700-0800 Sunrise Session: The role of inhaled antibiotics
0800-0840 PLENARY 2 (P2)
Title: Lung disease of prematurity and long term outcome 
0840-1010 SYMPOSIUM 4 (S4)
S4A - Asthma
• Severe asthma – what to do when the inhalers don’t work
• The role of biomarkers in asthma management
• mHealth to improve patient management

S4B - Non-invasive ventilation
• The effect of transnasal insufflation
• Home BiPAP in the management of COPD
• Neuromuscular diseases

S4C - Craniofacial deformity and impact on respiratory system
• Common craniofacial syndromes and their comorbidities
• Airway complications and management
• Management of other co-morbidities
1010-1040 Coffee break
1040-1210 SYMPOSIUM 5 (S5)
S5A - Lung cancer
• Lung cancer screening
• Re-biopsies in known cases of lung cancer
• Immunotherapy in lung cancer

S5B - Respiratory infections
• MDRO in the ICU
• Invasive aspergillosis
• Preparing for the next flu pandemic

S5C - Congenital airway and diaphragm defects in children
• Congenital airway and diaphragm defects: From common to rare
• Outcome and management of survivors
• Respiratory complications
1210-1300 SPONSORED SYMPOSIUM 5 (SS5)
Company: Boehringer Ingelheim
1300-1400 Lunch
1400-1530 Multi-disciplinary case discussions (physician/radiologist/pathologist)
1520-1620 CONCURRENT ORAL AND POSTER PRESENTATIONS
1630-1720 SPONSORED SYMPOSIUM 6A (SS6)
Company: Novartis
1720-1750 Coffee break
1800-1850 SPONSORED SYMPOSIUM 7 (SS7)
Company: GlaxoSmithKline Pharmaceutical
2000-2200 MTS GALA DINNER
Launch of Asthma Malaysia

SUNDAY, 23RD JULY 2017

0700-0800 Sunrise Session: Critical care medicine for the respiratory physician
0800-0840 PLENARY 3 (P3)
Title: The National Strategic Plan for Tobacco Control
0840-1010 SYMPOSIUM 6 (S6)
S6A - Tuberculosis II
• Drug resistant TB
• Update on HIV/TB co-infection
• Novel anti-tuberculous medication

S6B - Interventional Respiratory Techniques
• Navigational bronchoscopy
• Pleural interventions
• Endobronchial thermoplasty

S6C - Inherited metabolic and genetic diseases in children
• Inherited metabolic diseases: What the paediatrician should know
• Respiratory management in inherited metabolic diseases
• Congenital skeletal abnormalities and respiratory insufficiency
1010-1040 Coffee break
1040-1130 SPONSORED SYMPOSIUM 8 (SS8)
Company: Mundipharma
1130-1230 Forum: The role of clinicians in patient advocacy
1230-1240 Closing Ceremony
1240-1410 Lunch

 

This C​onference has been accredited for CPD points as follows:

  • MMC CPD Grading System
    Congress workshop on 20th July 2017- 6 CPD points under Category A3
    Conference from 21st to 23rd July 2017 – 20 CPD points under Category A1

  • Malaysian Nursing Board
    Congress workshop on 20th July 2017​ - 10 CPD points under Category A1
    Conference from 21st to 23rd July 2017 – 20 CPD points under Category A1

The Venue

Sunway Putra Hotel - It is a renowned 5-star international hotel in Kuala Lumpur offers business & leisure travellers a homelike experience.

Address: 100 Jalan Putra, 50350 Kuala Lumpur, Malaysia
Tel: 603 4040 9888
Fax: 603 4043 0700
Website: www.putra.sunwayhotel.com